论文期刊

取消

高级检索

检索历史清除

首页> Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie> Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K/AKT signaling pathway.

Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K/AKT signaling pathway.

导出 LinkOut

翻译打印收藏纠错

作者： Kai,Zhan ^[1] ; Rui,Liu ^[2] ; Hang,Tong ^[1] ; Shun,Gao ^[1] ; Guang,Yang ^[1] ; Arman,Hossain ^[3] ; Tinghao,Li ^[1] ; Weiyang,He ^[4]

作者单位： Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China; Central Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. ^[1] Department of Oncology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China. ^[2] Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. ^[3] Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Electronic address: weiyang361@aliyun.com. ^[4]

关键词 Epithelial–mesenchymal transition (EMT)Fetuin B (FETUB)PI3K/AKT Prostate cancer

主题词老年人(Aged);动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);细胞运动(Cell Movement);细胞增殖(Cell Proliferation);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);男(雄)性(Male);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);中年人(Middle Aged);肿瘤侵润(Neoplasm Invasiveness);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);前列腺肿瘤(Prostatic Neoplasms);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);信号传导(Signal Transduction);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)

DOI 10.1016/j.biopha.2020.110689

PMID 32892030

发布时间 2021-02-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

110689页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷